Vemurafenib - PDFSEARCH.IO - Document Search Engine

Vemurafenib
Results: 105

#	Item
21	dabrafenib, 50mg and 75mg hard capsules (Tafinlar®) GlaxoSmithKline SMC No. (No[removed]February 2015 Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Oncology Melanoma Organochlorides Vemurafenib Dacarbazine Ipilimumab BRAF Protein kinase inhibitor End point of clinical trials Chemistry Medicine Organofluorides
22	MSAC Application 1207: Consultation Decision Analytical Protocol (DAP) to guide the assessment of BRAF genetic testing in patients with melanoma for access to proposed PBS-funded GSK2118436 treatment January 2012 Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:50:11 Vemurafenib Cancer Metastasis Protein kinase inhibitor Medicine Melanoma BRAF
23	Public Summary Document Application No. 1172 – BRAF Genetic Testing in patients with melanoma for access to proposed PBS vemurafenib Applicant: Roche Diagnostics Pty. Ltd. Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:34 Melanoma Organochlorides Organofluorides Vemurafenib BRAF Sensitivity and specificity High Resolution Melt Positive predictive value Genetic testing Statistics Biology Biostatistics
24	Public Summary Document Application No. 1207 – Testing for V600 status in patients with locally advanced or metastatic melanoma for eligibility for dabrafenib treatment Sponsor/Applicant/s: Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:50:13 Organofluorides Sulfonamides Vemurafenib BRAF Protein kinase inhibitor Pharmaceutical Benefits Scheme Metastasis Melbourne Sports and Aquatic Centre Medicine Melanoma Organochlorides
25	1207: Final Decision Analytical Protocol (DAP) to guide the assessment of BRAF V600 mutation testing in patients with locally advanced or metastatic melanoma for eligibility for dabrafenib treatment Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:50:12 Vemurafenib Metastasis Protein kinase inhibitor Cancer Raf kinase Skin cancer Ipilimumab Medicine Melanoma BRAF
26	Public Summary Document Application No. 1172 – BRAF Genetic Testing in patients with melanoma for access to proposed PBS vemurafenib Applicant: Roche Diagnostics Pty. Ltd. Date of MSAC consideration: 2 August[removed]. Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:33 Biotechnology Molecular biology Biostatistics Melanoma BRAF Oncogenes Vemurafenib High Resolution Melt Sensitivity and specificity Statistics Biology Chemistry
27	Microsoft Word - Consultation DAP_1207_BRAF V600 _GSK2118436_.doc Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:50:13 Melanoma Organochlorides Organofluorides Vemurafenib BRAF Raf kinase Cancer Skin cancer Protein kinase inhibitor Medicine Oncology Oncogenes
28	DOCX Document Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:33 Melanoma Organochlorides Sulfonamides Vemurafenib BRAF Melbourne Sports and Aquatic Centre Pharmaceutical Benefits Scheme Mutation testing Cancer Medicine Health Healthcare in Australia
29	Public Summary Document Application No. 1172 – BRAF genetic testing in patients with melanoma for access to proposed PBS-funded vemurafenib Sponsor/Applicant/s: Roche Diagnostic Australia Pty Limited and Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:49:33 Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Pharmaceutical Benefits Scheme Melbourne Sports and Aquatic Centre Mutation testing Ipilimumab Medicine Health Melanoma
30	Public Summary Document Application No.1207 – BRAF V600 mutation testing associated with access to PBS-listed dabrafenib Add to Reading List Source URL: www.msac.gov.au Language: English - Date: 2014-11-06 23:50:11 Melanoma Organochlorides Sulfonamides Vemurafenib BRAF Protein kinase inhibitor Pharmaceutical Benefits Scheme Metastasis Melbourne Sports and Aquatic Centre Medicine Healthcare in Australia Health